MedDay completes patient enrolment in Phase III trial
            
            PARIS: MedDay Pharmaceuticals has completed patient enrolment in the SPI2 Phase III clinical trial evaluating…
            
            PARIS: MedDay Pharmaceuticals has completed patient enrolment in the SPI2 Phase III clinical trial evaluating…